Search alternatives:
step decrease » sizes decrease (Expand Search), we decrease (Expand Search)
teer decrease » mean decrease (Expand Search), greater decrease (Expand Search)
nn decrease » _ decrease (Expand Search), mean decrease (Expand Search), gy decreased (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
2 step » _ step (Expand Search), a step (Expand Search)
step decrease » sizes decrease (Expand Search), we decrease (Expand Search)
teer decrease » mean decrease (Expand Search), greater decrease (Expand Search)
nn decrease » _ decrease (Expand Search), mean decrease (Expand Search), gy decreased (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
2 step » _ step (Expand Search), a step (Expand Search)
-
6661
-
6662
-
6663
-
6664
-
6665
-
6666
-
6667
-
6668
-
6669
-
6670
-
6671
-
6672
-
6673
Irreversible activation of CrGluClα by ivermectin.
Published 2014“…<p>A. Current trace obtained at 60 mV during bath application of 50 µM glutamate and then to ivermectin at concentrations going from 1 to 3000 nM during the times shown in the boxes. …”
-
6674
Bioactive Sesquiterpenoids from the Peeled Stems of <i>Syringa pinnatifolia</i>
Published 2018“…These compounds decreased the TNF-α and IL-6 levels in RAW264.7 cells in a concentration-dependent manner at 20–80 μM.…”
-
6675
Bioactive Sesquiterpenoids from the Peeled Stems of <i>Syringa pinnatifolia</i>
Published 2018“…These compounds decreased the TNF-α and IL-6 levels in RAW264.7 cells in a concentration-dependent manner at 20–80 μM.…”
-
6676
Bioactive Sesquiterpenoids from the Peeled Stems of <i>Syringa pinnatifolia</i>
Published 2018“…These compounds decreased the TNF-α and IL-6 levels in RAW264.7 cells in a concentration-dependent manner at 20–80 μM.…”
-
6677
Bioactive Sesquiterpenoids from the Peeled Stems of <i>Syringa pinnatifolia</i>
Published 2018“…These compounds decreased the TNF-α and IL-6 levels in RAW264.7 cells in a concentration-dependent manner at 20–80 μM.…”
-
6678
-
6679
Discovery of Bifunctional Oncogenic Target Inhibitors against Allosteric Mitogen-Activated Protein Kinase (MEK1) and Phosphatidylinositol 3‑Kinase (PI3K)
Published 2016“…Concurrent MEK1 and PI3K inhibition was demonstrated with inhibitors <b>9</b> and <b>14</b> in two tumor cell lines (A549, D54). Inhibitors produced dose-dependent decreased cell viability similar to the combined administration of equivalent doses of ZSTK474 and PD0325901. …”
-
6680